Biocon Limited (BOM:532523)
India · Delayed Price · Currency is INR 414.05
+1.95 (0.47%)
At close: Aug 21, 2026
Biocon Market Cap
Biocon has a market cap or net worth of 672.99 billion as of August 21, 2026. Its market cap has increased by 40.30% in one year.
Market Cap
672.99B
Enterprise Value
814.39B
Revenue
173.21B
Ranking
n/a
PE Ratio
135.87
Stock Price
414.05
ChartMarket Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 672.99B, an increase of 1,381.92%. That is a compound annual growth rate of 12.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 672.99B | 28.03% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aarti Drugs | 37.28B |
| Hester Biosciences | 20.50B |
| Titan Biotech | 16.47B |
| Zenotech Laboratories | 2.83B |
| CCME Global | 2.56B |
| Bharat Immunologicals & Biologicals Corporation | 692.18M |
| Transgene Biotek | 207.61M |
| Hindustan Bio Sciences | 71.24M |